Advertisement
MBX Biosciences, Inc. Common Stock

MBX Biosciences, Inc. Common Stock (MBX) Stock Overview

Explore MBX Biosciences, Inc. Common Stock’s financial performance, market position, analyst ratings, and future outlook.

MBX●NASDAQ
HealthcareBiotechnology
$30.22
$0.43(1.41%)
U.S. Market is Open · 13:25
Advertisement

MBX Biosciences, Inc. Common Stock (MBX)

Meyka AI Score

Z

Key Financials

Market Cap1B
P/E Ratio-16.24
EPS (TTM)$-2.17
ROE-0.25%
Fundamental Analysis

AI Price Forecasts

1 Month$33.36
3 Months$53.58
1 Year Target$43.88

MBX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of MBX Biosciences, Inc. Common Stock (MBX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 44.03, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $43.88.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -16.24 and a market capitalization of 1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.16%
5-Day Change
-3.46%
1-Month Change
3.09%
3-Month Change
-6.89%
6-Month Change
-7.42%
Year-to-Date (YTD) Change
-2.66%
1-Year Change
133.64%
3-Year Change
29.81%
5-Year Change
29.81%
All-Time (Max) Change
29.81%

Contact Information

https://mbxbio.com
(317) 659-0200
11711 N. Meridian Street, Carmel, IN, 46032

Company Facts

43 Employees
IPO DateJan 14, 2000
CountryUS
Actively Trading

Frequently Asked Questions